Marlys Hammond

1.1k citations

24 papers · 778 indexed · h-index 15

Co-authors: Andrew G. Myers Yusheng Wu Stephen W. Kaldor Jeffrey Aubé Philip M. Harrington Elaine Y. Kuo Jaclyn R. Patterson Scott K. Thompson
Topics: Chemical Synthesis and Analysis (6 papers)Chemical synthesis and alkaloids (6 papers)Estrogen and related hormone effects (4 papers)
Cited by: Organic Chemistry Sensory Systems Toxicology
Journals: Journal of the American Chemical Society Cancer Research Journal of Medicinal Chemistry
Partner nations: United States United Kingdom

In The Last Decade

Marlys Hammond

24 papers receiving 756 citations

Peers

Countries citing papers authored by Marlys Hammond

Since Specialization

Citations

This map shows the geographic impact of Marlys Hammond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlys Hammond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlys Hammond more than expected).

Fields of papers citing papers by Marlys Hammond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marlys Hammond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlys Hammond. The network helps show where Marlys Hammond may publish in the future.

Co-authorship network of co-authors of Marlys Hammond

This figure shows the co-authorship network connecting the top 25 collaborators of Marlys Hammond. A scholar is included among the top collaborators of Marlys Hammond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marlys Hammond. Marlys Hammond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of GSK2798745: A Clinical Candidate for Inhibition of Transient Receptor Potential Vanilloid 4 (TRPV4) 2019 ·ACS Medicinal Chemistry Letters ·(unknown),(unknown),David J. Behm,Hilary S. Eidam,(unknown),Marlys Hammond,Tram H. Hoang,Dennis A. Holt,Mark A. Hilfiker,Brian G. Lawhorn,Jaclyn R. Patterson,Patrick Stoy,Theresa J. Roethke,Guosen Ye,(unknown),Kevin S. Thorneloe,Krista Goodman,Mui Cheung	36
2	2-Amino-9-aryl-3-cyano-4-methyl-7-oxo-6,7,8,9-tetrahydropyrido[2′,3′:4,5]thieno[2,3-b]pyridine derivatives as selective progesterone receptor agonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·Yonghui Wang,Chaya Duraiswami,Kevin P. Madauss,Thuy Tran,Shawn P. Williams,Su-Jun Deng,Todd L. Graybill,Marlys Hammond,David G. Jones,Eugene T. Grygielko,Jeffrey D. Bray,Scott K. Thompson	11
3	Bioisosteric replacement of the hydrazide pharmacophore of the cannabinoid-1 receptor antagonist SR141716A. Part I: Potent, orally-active 1,4-disubstituted imidazoles 2009 ·Bioorganic & Medicinal Chemistry Letters ·Robert L. Dow,John R. Hadcock,Dennis O. Scott,(unknown),Ernest S. Paight,Philip A. Iredale,Philip A. Carpino,David A. Griffith,Marlys Hammond,Paul DaSilva‐Jardine	11
4	Discovery of orally active, pyrrolidinone-based progesterone receptor partial agonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·David G. Washburn,Tram H. Hoang,James S. Frazee,L.G. Johnson,Marlys Hammond,(unknown),Kevin P. Madauss,Shawn P. Williams,Chaya Duraiswami,Thuy Tran,Eugene L. Stewart,Eugene T. Grygielko,(unknown),Walter Trizna,Rakesh Nagilla,Jeffrey D. Bray,Scott K. Thompson	7
5	Synthesis and SAR of amino acid-derived heterocyclic progesterone receptor full and partial agonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·Marlys Hammond,Jaclyn R. Patterson,(unknown),Tram H. Hoang,David G. Washburn,Walter Trizna,(unknown),Eugene T. Grygielko,Rakesh Nagilla,(unknown),Harvey E. Fries,Douglas J. Minick,Nicholas J. Laping,Jeffrey D. Bray,Scott K. Thompson	10
6	Design and synthesis of orally bioavailable serum and glucocorticoid-regulated kinase 1 (SGK1) inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Marlys Hammond,David G. Washburn,Tram H. Hoang,(unknown),James S. Frazee,Hiroko Nakamura,Jaclyn R. Patterson,Walter Trizna,Charlene Wu,Leonard M. Azzarano,Rakesh Nagilla,(unknown),(unknown),Martha S. Head,Baoguang Zhao,Angela Smallwood,Kendra E. Hightower,Nicholas J. Laping,Christine G. Schnackenberg,Scott K. Thompson	37
7	Development of a Small-Molecule Serum- and Glucocorticoid-Regulated Kinase-1 Antagonist and Its Evaluation as a Prostate Cancer Therapeutic 2008 ·Cancer Research ·Andrea B. Sherk,Daniel E. Frigo,Christine G. Schnackenberg,Jeffrey D. Bray,Nicholas J. Laping,Walter Trizna,Marlys Hammond,Jaclyn R. Patterson,Scott K. Thompson,Dmitri Kazmin,John D. Norris,Donald P. McDonnell	174
8	Structure–activity relationship studies on 2-heteroaryl-4-arylimidazoles NPY5 receptor antagonists 2003 ·Bioorganic & Medicinal Chemistry Letters ·Richard L. Elliott,Robert M. Oliver,(unknown),(unknown),Marlys Hammond,(unknown),Tristan S. Maurer,(unknown),Paul DaSilva‐Jardine,Ralph W. Stevenson,Christine M. Mack,James V. Cassella	24
9	Structure–activity relationships in a series of NPY Y5 antagonists: 3-amido-9-ethylcarbazoles, core-modified analogues and amide isosteres 2003 ·Bioorganic & Medicinal Chemistry Letters ·Marlys Hammond,Richard L. Elliott,(unknown),David C. Hager,(unknown),(unknown),Robert M. Oliver,Paul DaSilva‐Jardine,Ralph W. Stevenson,Christine M. Mack,James V. Cassella	10
10	Development of an Enantioselective Synthetic Route to Neocarzinostatin Chromophore and Its Use for Multiple Radioisotopic Incorporation 2002 ·Journal of the American Chemical Society ·Andrew G. Myers,Ralf Glatthar,Marlys Hammond,Philip M. Harrington,Elaine Y. Kuo,Jun Liang,Scott E. Schaus,Yusheng Wu,Jia‐Ning Xiang	60
11	Total Synthesis of (+)-Neocarzinostatin Chromophore 1998 ·Journal of the American Chemical Society ·Andrew G. Myers,Jun Liang,Marlys Hammond,Philip M. Harrington,Yusheng Wu,Elaine Y. Kuo	50
12	A Comparison of DNA Cleavage by Neocarzinostatin Chromophore and Its Aglycon: Evaluating the Role of the Carbohydrate Residue 1997 ·Journal of the American Chemical Society ·Andrew G. Myers,Michael E. Kort,Marlys Hammond	32
13	A concise synthesis of the naphthoic acid component of neocarzinostatin chromophore featuring a new photocyclization reaction 1996 ·Tetrahedron Letters ·Andrew G. Myers,(unknown),Marlys Hammond	13
14	An improved preparation of highly enantiomerically enriched (R)-(+)-4-tert-butyldimethylsiloxy-2-cyclopenten-1-one 1996 ·Tetrahedron Letters ·Andrew G. Myers,Marlys Hammond,Yusheng Wu	34
15	A systematic study of P1–P3 spanning sidechains for the inhibition of HIV-1 protease 1995 ·Bioorganic & Medicinal Chemistry Letters ·Stephen W. Kaldor,Krzysztof Appelt,James E. Fritz,Marlys Hammond,Thomas A. Crowell,(unknown),(unknown),(unknown),Mark A. Muesing	7
16	Glutamine-derived aldehydes for the inhibition of human rhinovirus 3C protease 1995 ·Bioorganic & Medicinal Chemistry Letters ·Stephen W. Kaldor,Marlys Hammond,Bruce A. Dressman,(unknown),(unknown),Allen D. Kline,Beverly A. Heinz	34
17	Isophthalic acid derivatives: amino acid surrogates for the inhibition of HIV-1 protease 1995 ·Bioorganic & Medicinal Chemistry Letters ·Stephen W. Kaldor,Bruce A. Dressman,Marlys Hammond,Krzysztof Appelt,Jeffrey A. Burgess,(unknown),Mark A. Muesing,(unknown),M. WISKERCHEN,(unknown)	13
18	A mild, osmium tetraoxide-catalyzed method for the oxidation of sulfides to sulfones 1991 ·Tetrahedron Letters ·Stephen W. Kaldor,Marlys Hammond	48
19	Directed regiochemical control in the ring expansion reactions of a substituted trans-decalone 1990 ·Tetrahedron Letters ·Jeffrey Aubé,Marlys Hammond	27
20	Synthetic aspects of an asymmetric nitrogen-insertion process: preparation of chiral, non-racemic caprolactams and valerolactams. Total synthesis of (-)-alloyohimbane 1990 ·Journal of the American Chemical Society ·Jeffrey Aubé,Yuguang Wang,Marlys Hammond,(unknown),Fusao Takusagawa,David Vander Velde	48

About Marlys Hammond

Marlys Hammond is a scholar working on Toxicology, Organic Chemistry and Virology, having authored 24 papers that have together received 778 indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (6 papers), Chemical synthesis and alkaloids (6 papers) and Estrogen and related hormone effects (4 papers). The work is most often cited by research in Organic Chemistry (426 citations), Sensory Systems (34 citations) and Toxicology (21 citations). Marlys Hammond has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Andrew G. Myers, Yusheng Wu, Stephen W. Kaldor, Jeffrey Aubé, Philip M. Harrington, Elaine Y. Kuo, Jaclyn R. Patterson, Scott K. Thompson, Walter Trizna and Nicholas J. Laping. Their work appears in journals such as Journal of the American Chemical Society, Cancer Research and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact